NM_015458.4(MTMR9):c.1605G>T (p.Gln535His) AND not specified

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Sep 22, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004514649.1

Allele description [Variation Report for NM_015458.4(MTMR9):c.1605G>T (p.Gln535His)]

NM_015458.4(MTMR9):c.1605G>T (p.Gln535His)

Genes:

MTMR9:myotubularin related protein 9 [Gene - OMIM - HGNC]
LOC101929290:uncharacterized LOC101929290 [Gene]

Variant type:

single nucleotide variant

Cytogenetic location:

8p23.1

Genomic location:

Preferred name:

NM_015458.4(MTMR9):c.1605G>T (p.Gln535His)

HGVS:

NC_000008.11:g.11322743G>T
NM_015458.4:c.1605G>TMANE SELECT
NP_056273.2:p.Gln535His
NC_000008.10:g.11180252G>T
NM_015458.3:c.1605G>T

Protein change:

Q535H

Molecular consequence:

NM_015458.4:c.1605G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Acyl Carrier Protein
Acyl Carrier Protein
Consists of a polypeptide chain and 4'-phosphopantetheine linked to a serine residue by a phosphodiester bond. Acyl groups are bound as thiol esters to the pantothenyl group. ... Year introduced: 1978

MeSH
Calmodulin-Binding Proteins
Calmodulin-Binding Proteins
Proteins which bind calmodulin. They are found in many tissues and have a variety of functions including F-actin cross-linking properties, inhibition of cyclic nucleotide phos... Year introduced: 1986

MeSH
Protein Inhibitors of Activated STAT
Protein Inhibitors of Activated STAT
A family of structurally related proteins that are constitutively expressed and that negatively regulate cytokine-mediated SIGNAL TRANSDUCTION PATHWAYS. PIAS proteins inhibit ... Year introduced: 2006(1998)

MeSH
Lipocalin 1
Lipocalin 1
A lipocalin that was orignally characterized from human TEARS. It is expressed primarily in the LACRIMAL GLAND and the VON EBNER GLANDS. Lipocalin 1 may play a role in olfacto... Year introduced: 2008(1990)

MeSH
GRB10 Adaptor Protein
GRB10 Adaptor Protein
A binding partner for several RECEPTOR PROTEIN-TYROSINE KINASES, including INSULIN RECEPTOR and INSULIN-LIKE GROWTH FACTOR RECEPTOR. It contains a C-terminal SH2 DOMAIN and me... Year introduced: 2006(1995)

MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV005009127	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Sep 22, 2023)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV005009127

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Sep 22, 2023)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV005009127.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The c.1605G>T (p.Q535H) alteration is located in exon 10 (coding exon 10) of the MTMR9 gene. This alteration results from a G to T substitution at nucleotide position 1605, causing the glutamine (Q) at amino acid position 535 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 1, 2024

ClinVar

Relating variation to medicine